Cost checklist · Payment
Ask for a written breakdown of the medicine, visits, tests and follow-up. Write beside each price whether you would pay it yourself or use insurance.
What would I pay after an introductory offer ends, and how do I cancel?
As of September 26, 2026, the government price page listed tirzepatide (Zepbound) from $299 per month.
That starting figure applied to the lowest strength, meaning the smallest amount of medicine per injection; it was not a price for every prescription.
A drug maker’s published figure is its list price; a cash offer or an insurance copay means something different.
The patient’s share of a bill covered by insurance is called a copay.
Ask for the price for your exact prescription, both with insurance and if you pay yourself. Write down what is included and when the offer ends.
For people using Medicare
Part D means Medicare prescription-drug coverage.
As of September 2026, qualifying Part D members pay a $50 monthly copay under the temporary Medicare GLP-1 Bridge program.
The September 2026 check gives a scheduled start of July 1, 2026 and an end of December 31, 2027.
For tirzepatide (Zepbound), Bridge covers only the KwikPen, an injection pen holding several doses, as of September 2026.
Single-dose pens, used for one injection, and vials, small medicine bottles, are excluded from Bridge, as of September 2026.
To apply, you need a prescription and program approval, and must be at least 18, as of September 2026.
Your coverage, as of September 2026, must be either a separate drug plan under Part D or an eligible Medicare Advantage plan that includes medicines.
As of September 2026, the health rules use body mass index (BMI), a figure calculated from height and weight.
Ask whoever writes your prescription to compare your health records with the precise health rules. Ask your plan whether its type of coverage is included.
As of September 2026, the $50 you pay for Bridge does not go toward the annual limit on your medicine spending through normal Part D coverage.
So these payments do not bring you closer to that cap, even though the money comes out of your pocket.
You cannot use a coupon to reduce a prescription’s $50 Bridge payment, as of September 2026.
The usual Part D insurance process is separate from Bridge’s temporary $50 program, as of September 2026.
Medicare’s usual Part D rules may cover tirzepatide (Mounjaro) when it is prescribed for type 2 diabetes, as of September 2026.
Zepbound may be covered, as of September 2026, for adults with obesity whose obstructive sleep apnea is moderate to severe.
This means repeated breathing blockages during sleep; the severity and weight requirements matter.
People with type 2 diabetes or this sleep condition must check usual Part D coverage rather than Bridge, as of September 2026.
Possible coverage does not guarantee that your plan will pay; check its list of covered medicines and approval rules.
Prior authorization means the plan must approve payment before the pharmacy fills the prescription.